By Alexander Chong
At the moment in the evenings or early mornings, when we start to have runny and blocked nose together with sneezing, we quickly think that our environment may contain dust mites or the air conditions cause us allergic. Some of us may not know whether we are actually suffering from allergy or common cold. So when a person s….
http://www.prisonplanet.com/
Not familiar with this scientific research? Your government is.
In fact, the first experiment documenting pot’s potent anti-cancer effects took place in 1974 at the Medical College of Virginia at the behest federal bureaucrats. The results of that study, reported in an Aug. 18, 1974, Washington Post newspaper feature, were that marijuana’s primary psychoactive component, THC, “slowed the growth of lung cancers, breast cancers and a virus-induced leukemia in laboratory mice, and prolonged their lives by as much as 36 percent.”
Despite these favorable preliminary findings (eventually published the following year in the Journal of the National Cancer Institute), U.S. government officials refused to authorize any follow-up research until conducting a similar though secret preclinical trial in the mid-1990s. That study, conducted by the U.S. National Toxicology Program to the tune of $2 million, concluded that mice and rats administered high doses of THC over long periods had greater protection against malignant tumors than untreated controls.
However, rather than publicize their findings, the U.S. government shelved the results, which only became public after a draft copy of its findings were leaked to the medical journal AIDS Treatment News, which in turn forwarded the story to the national media.
In the years since the completion of the National Toxicology trial, the U.S. government has yet to authorize a single additional study examining the drug’s potential anti-cancer properties. (Federal permission is necessary in order to conduct clinical research on marijuana because of its illegal status as a schedule I controlled substance.)
Fortunately, in the past 10 years scientists overseas have generously picked up where U.S. researchers so abruptly left off, reporting that cannabinoids can halt the spread of numerous cancer cells including prostate cancer, breast cancer, lung cancer, pancreatic cancer, and brain cancer. (An excellent paper summarizing much of this research, “Cannabinoids for Cancer Treatment: Progress and Promise,” appears in the January 2008 edition of the journal Cancer Research.) A 2006 patient trial published in the British Journal of Cancer even reported that the intracranial administration of THC was associated with reduced tumor cell proliferation in humans with advanced glioblastoma.
Writing earlier this year in the scientific journal Expert Review of Neurotherapeutics, Italian researchers reiterated, “(C)annabinoids have displayed a great potency in reducing glioma tumor growth. (They) appear to be selective antitumoral agents as they kill glioma cells without affecting the viability of nontransformed counterparts.” Not one mainstream media outlet reported their findings. Perhaps now they’ll pay better attention.
What possible advancements in the treatment of cancer may have been achieved over the past 34 years had U.S. government officials chosen to advance rather than suppress clinical research into the anti-cancer effects of cannabis? It’s a shame we have to speculate; it’s even more tragic that the families of Senator Kennedy and thousands of others must suffer while we do.
http://www.infowars.com/?p=2894
Author: civilian37
Keywords: infowars kevin booth american drug war pot anti-cancer organic herb genesis one eleven bible god sent healing nations life extension wholesome good vs evil
Added: June 27, 2008
Renewed Hope for Stage Four Breast Cancer Patients
Even though most women know the importance of early detection and yearly screenings in the fight against breast cancer, each year thousands receive a devastating diagnosis of stage four breast cancer. In fact, each year more than one-in-four breast cancer patients are diagnosed with a highly aggressive breast cancer known as HER-2 neu positive, which until recently was considered seldom treatable.
Now a new therapy monitoring test, Siemens HER-2/neu blood test, is giving renewed hope to metastatic breast cancer patients. The test is the only FDA cleared serum HER-2/neu blood test, which can indicate whether metastatic breast cancer is progressing or responding to treatment. By combining advanced drug therapies, routine mammograms, advanced breast ultrasounds and MRIs, doctors have been able to fight many metastatic cancers more effectively.
Source: Siemens
Author: Medialink
Keywords: blood breast cancer drug her metastatic neu positive siemens test therapies treatment
Added: October 20, 2008
Breast Cancer (Part1)
Dr Khoo Kei Siong talks about the equipment used in breast cancer management and treatment. WARNING: SOME IMAGES CONTAINED IN THIS VIDEO MAY BE CONSIDERED DISTURBING TO SOME VIEWERS. VIEWER DISCRETION IS ADVISED.
Author: olivemed
Keywords: medical breast cancer treatment doctor therapy advance drugs chemotherapy radiation consult
Added: April 21, 2008
More info…
In this cancer resource, you will find information about symptoms of several types of cancer, cancer causes, treatment and more. Cancer Prevention and risk factors such as HPV …
Cancer (Malignant Tumor) Types, Facts, Survival Rates, Statistics and …
Learn about cancer types, disease statistics, facts, and survival rates, and get information about how malignant tumors (cancerous growths) metastasize or spread.
Cancer (constellation) - Wikipedia, the free encyclopedia
Cancer (IPA:, /kns/, Latin: crab, symbol , Unicode ) is one of the twelve constellations of the zodiac. Cancer is small and dim, and to many it does not resemble a crab.
Wades auctions his dreads supporting our friend Sandra as she recovers from radiation therapy for breast cancer.
Author: nudlman
Keywords: dreads cancer
Added: December 8, 2008